financetom
Business
financetom
/
Business
/
Pramod Mittal, man who spent equivalent of Rs 505 crore on daughter's wedding, goes bankrupt
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Pramod Mittal, man who spent equivalent of Rs 505 crore on daughter's wedding, goes bankrupt
Oct 22, 2020 6:27 AM

Pramod Mittal, the brother of Indian steel magnate Lakshmi Mittal, has gone bankrupt.

Share Market Live

NSE

According to a report by The Times, Mittal was declared as bankrupt by London's Insolvency and Companies Court, and has an estimated debt of more than 130 million pounds.

Mittal's debt woes began 14 years ago when he agreed to become a guarantor for debts of a Bosnian coke producer named Global Ispat Koksna Industrija Lukavac (GIKIL). The company failed to repay $166 million.

Mittal claimed that he owes about 170 million pounds to his father, about 1.1 million to his wife Sangeeta, 2.4 million pounds to his son Divyesh and about 1.1 million pounds to his brother-in-law.

The businessman's assets are valued at 110,000 pounds. Furthermore, Mittal claimed to have "no personal income" and a measly 45 pounds (or Rs 4,300) worth of property near Delhi.

Reports said Mittal has offered to pay back 0.18 of a penny for every pound he owes.

In a statement, Mittal said, "I have no personal income. My wife is financially independent from me. We have separate bank accounts and I have very limited information regarding her income. My personal expenditure of approximately 2,000 pounds to 3,000 pounds per month is mainly met by my wife and family. The legal costs of my bankruptcy are being met by another third party."

The UK-based businessman made news when he married off his daughter in 2013, when he spent 50 million pounds, or about Rs 505 crore.

Mittal has found himself in trouble with the law before: he was arrested in Bosnia last year with two of his company officials in an alleged case of fraud. In India he is facing a money-laundering investigation for suspected fraud of Rs 2,200 crore with the State Trading Corporation (STC).

First Published:Oct 22, 2020 3:27 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Bristol Myers faces renewed, $6.7 billion lawsuit over delayed cancer drug
Bristol Myers faces renewed, $6.7 billion lawsuit over delayed cancer drug
Nov 15, 2024
NEW YORK (Reuters) - Bristol Myers Squibb was hit on Thursday with a $6.7 billion lawsuit claiming it cheated former Celgene shareholders by delaying federal approval for three drugs, 1-1/2 months after a federal judge abruptly dismissed an earlier version of the case. The lawsuit accused Bristol Myers of depriving holders of contingent value rights (CVR) an extra $9 per...
US man sentenced to 5 years over laundering crypto stolen from Bitfinex hack
US man sentenced to 5 years over laundering crypto stolen from Bitfinex hack
Nov 15, 2024
WASHINGTON (Reuters) - A New York technology entrepreneur was sentenced to five years in prison on Thursday after pleading guilty last year to laundering funds stolen from Bitfinex one of the world's largest cryptocurrency exchanges, with the help of his wife. Ilya Lichtenstein, 35, hacked into Bitfinex's network in 2016, using advanced hacking tools and techniques, and stole about 120,000...
Glenview, Sachem Head, Third Point buy CVS shares during Q3-filings
Glenview, Sachem Head, Third Point buy CVS shares during Q3-filings
Nov 15, 2024
NEW YORK, Nov 14 (Reuters) - Three prominent investment firms bet changes are in the offing at ailing healthcare giant CVS Health ( CVS ) and added to existing bets and established a new position during the third quarter, according to regulatory filings. Longtime investor Glenview Capital Management bought 2.8 million CVS shares during the third quarter, increasing its stake...
Bristol Myers faces renewed, $6.7 bln lawsuit over delayed cancer drug
Bristol Myers faces renewed, $6.7 bln lawsuit over delayed cancer drug
Nov 15, 2024
NEW YORK, Nov 14 (Reuters) - Bristol Myers Squibb ( BMY ) was hit on Thursday with a $6.7 billion lawsuit claiming it cheated former Celgene shareholders by delaying federal approval for three drugs, 1-1/2 months after a federal judge abruptly dismissed an earlier version of the case. The lawsuit accused Bristol Myers of depriving holders of contingent value rights...
Copyright 2023-2026 - www.financetom.com All Rights Reserved